Sign in

CIK 0001211583

  • Non-accelerated filer
  • Smaller reporting company

FENNEC PHARMACEUTICALS INC.

Sign in to watch
Ticker
FENC
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
British Columbia, Canada
Entity type
Operating
Phone
+1 919-636-4530
Business address
PO BOX 13628, 68 TW ALEXANDER DRIVE, RESEARCH TRIANGLE PARK, NC, 27709
Former names
ADHEREX TECHNOLOGIES INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$1,550,718
in 5 filings, $1.4M under 10b5-1 plans

Net −$1,550,718. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-10-31 Hackman Jeffrey S. Chief Executive Officer Grant or award +1,159 70,844
2026-10-12 Hackman Jeffrey S. Chief Executive Officer Grant or award +2,224 $5.53 $12K 69,685
2026-09-30 Hackman Jeffrey S. Chief Executive Officer Grant or award +1,159 67,461
2026-08-31 Hackman Jeffrey S. Chief Executive Officer Grant or award +1,159 66,302
2026-07-31 Hackman Jeffrey S. Chief Executive Officer Grant or award +1,159 65,143
2026-06-30 Hackman Jeffrey S. Chief Executive Officer Grant or award +1,159 63,984
2026-05-31 Hackman Jeffrey S. Chief Executive Officer Grant or award +1,159 62,825
2026-04-30 Hackman Jeffrey S. Chief Executive Officer Option exercise +1,159 61,666
2026-03-31 Hackman Jeffrey S. Chief Executive Officer Option exercise +16,695 45,405
2026-03-31 Hackman Jeffrey S. Chief Executive Officer Option exercise +1,159 46,564
2026-03-31 Hackman Jeffrey S. Chief Executive Officer Grant or award · Stock Options +200,000 $5.77 $1.2M 725,000
2026-03-28 Hackman Jeffrey S. Chief Executive Officer Option exercise +13,943 60,507
2026-02-18 Hackman Jeffrey S. Chief Executive Officer Option exercise +13,710 28,710
2025-05-19 Hackman Jeffrey S. Chief Executive Officer Purchase +13,965 $6.99 $98K 15,000
2025-05-16 Hackman Jeffrey S. Chief Executive Officer Purchase +1,035 $6.75 $7K 1,035
2025-03-28 Hackman Jeffrey S. Chief Executive Officer Grant or award · Restricted Share Unit +75,000 475,000
2025-03-28 Hackman Jeffrey S. Chief Executive Officer Grant or award · Stock Options +50,000 525,000
2025-03-28 Hackman Jeffrey S. Chief Executive Officer Grant or award · Restricted Share Unit +75,000 75,000
2025-03-28 Hackman Jeffrey S. Chief Executive Officer Grant or award · Stock Options +50,000 450,000
2024-08-15 Hackman Jeffrey S. Chief Executive Officer Grant or award · Stock Options +400,000 $5.58 $2.2M 400,000

Page 1 of 1 · 20 trades